论著

3q26 rs12696304基因多态性与中国南方汉族老年人群急性心力衰竭患者一年预后间的关系研究

展开
  • 1.南京医科大学附属江宁医院肝胆胰外科,江苏 南京 211100
    2.南京医科大学第一附属医院a. 重症医学科,b. 心血管内科,江苏 南京 210029

收稿日期: 2020-09-23

  网络出版日期: 2022-07-14

基金资助

国家科技支撑计划课题(2011BAI11B08)

Correlation between gene polymorphism of chromosome 3q26 rs12696304 and 1-year survival rate after acute heart failure in an elderly Han population in South China

Expand
  • 1. Department of General Surgery, the Affiliated Jiangning Hospital of Nanjing Medical University, Jiangsu Nanjin 211100
    2a. ICU, 2b. Department of Cardiology, First Affiliate Hospital of Nanjing Medical University, Jiangsu Nanjin 210029, China

Received date: 2020-09-23

  Online published: 2022-07-14

摘要

目的: 研究3q26 rs12696304基因多态性与急性心力衰竭(急性心衰)患者1年预后间的关系。方法: 2012年3月至2016年4月间,收集南京医科大学第一附属医院收治的336例急性心衰患者(≥60岁)。采用TaqMan荧光探针实时定量聚合酶链式反应(polymerase chain reaction,PCR)技术法检测患者外周血DNA中的3q26 rs12696304基因多态性, 采用Kaplan-Meier法和log-rank检验,分析不同遗传模型下各基因型急性心衰患者1年的生存率;采用多因素Cox回归分析探讨3q26 rs12696304基因多态性与急性心衰患者1年预后间的相关性。结果: 在共显性遗传模型中,携带杂合子CG基因型的急性心衰患者其1年生存率(74.8%)比携带纯合子GG基因型患者(85.4%)低(CG比GG,P=0.027);在显性遗传模型中,携带CG+CC基因型急性心衰患者其生存率(74.9%)较纯合子GG基因型患者生存率(85.4%) 明显下降(P=0.023),CC+CG基因型急性心衰患者发生死亡的风险系数是GG基因型患者的2.45倍[风险比(hazard ratio,HR)=2.45,95%CI为1.24~4.84,P=0.010]。结论: 检测3q26 rs12696304基因多态性可能有助于评估中国南方汉族老年人群中急性心衰患者1年的预后情况。

本文引用格式

张中文, 左祥荣, 郑绪辉, 曹权, 李新立, 李艳秀 . 3q26 rs12696304基因多态性与中国南方汉族老年人群急性心力衰竭患者一年预后间的关系研究[J]. 诊断学理论与实践, 2020 , 19(06) : 565 -571 . DOI: 10.16150/j.1671-2870.2020.06.004

Abstract

Objective: To investigate the correlation between the gene polymorphism of rs12696304 in chromosome 3q26 and 1-year survival rate in the patients with acute heart failure (AHF). Methods: A total of 336 elderly patients of Han population in South China (aged≥60 years) with AHF were enrolled during March 2012 and April 2016. DNA of each patient was extracted from peripheral blood, and the gene polymorphism of rs12696304 was analyzed by real-time fluorescence quantitative PCR with TaqMan probe. One-year survival rate was compared between the patients with diffe-rent gene typing in multiple genetic models using Kaplan-Meier and log-rank test. The Cox regression analysis was used to assess relation between the gene polymorphism of rs12696304 and 1-year survival rate in the patients with AHF. Results: In the co-dominant genetic model, the 1-year survival rate of the AHF patients carrying heterozygous CG genotypes was lower than that of patients carrying wild homozygous GG genotypes (74.8% vs 85.4%, P=0.027). In the dominant genetic model, 1-year survival rate of the AHF patients carrying CG+CC genotype was significantly lower than that of patients carrying the wild homozygous GG genotype (74.9% vs 85.4%, P=0.023). Further Cox regression analysis showed that the risk of 1-year death in the AHF patients carrying CG+CC genotype was 2.45 times of that in the patients with GG genotype (HR=2.45, 95%CI: 1.22-4.95, P=0.012) after adjustment with the relevant variables in codominant model, and in the dominant model, the risk of 1-year death was also 2.45 times of that in patients with GG genotype (HR=2.45, 95%CI: 1.24-4.84, P=0.010). Conclusions: The gene polymorphisms of rs12696304 located in chromosome 3q26 region may be associated with the 1-year prognosis in the patients with AHF.

参考文献

[1] 胡盛寿, 高润霖, 刘力生, 等. 《中国心血管病报告2018》概要[J]. 中国循环杂志, 2019, 34(3):209-220.
[2] Yancy CW, Jessup M, Yancy CW, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines[J]. Circulation, 2013, 128(16):e240-e327.
[3] Smith NL, Felix JF, Morrison AC, et al. Association of genome-wide variation with the risk of incident heart fai-lure in adults of European and African ancestry: a prospective meta-analysis from the cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium[J]. Circ Cardiovasc Genet, 2010, 3(3):256-266.
[4] Morrison AC, Felix JF, Cupples LA, et al. Genomic varia-tion associated with mortality among adults of European and African ancestry with heart failure: the cohorts for heart and aging research in genomic epidemiology consortium[J]. Circ Cardiovasc Genet, 2010, 3(3):248-255.
[5] Fox ER, Musani SK, Barbalic M, et al. Genome-wide association study of cardiac structure and systolic function in African Americans: the Candidate Gene Association Resource (CARe) study[J]. Circ Cardiovasc Genet, 2013, 6(1):37-46.
[6] Gabisonia K, Recchia FA. Gene therapy for heart failure: new perspectives[J]. Curr Heart Fail Rep, 2018, 15(6):340-349.
[7] Maubaret CG, Salpea KD, Romanoski CE, et al. Association of TERC and OBFC1 haplotypes with mean leukocyte telomere length and risk for coronary heart disease[J]. PLoS One, 2013, 8(12):e83122.
[8] Kark JD, Nassar H, Shaham D, et al. Leukocyte telomere length and coronary artery calcification in Palestinians[J]. Atherosclerosis, 2013, 229(2):363-368.
[9] Willeit P, Willeit J, Brandstätter A, et al. Cellular aging reflected by leukocyte telomere length predicts advanced atherosclerosis and cardiovascular disease risk[J]. Arterioscler Thromb Vasc Biol, 2010, 30(8):1649-1656.
[10] Cheng G, Wang L, Dai M, et al. Shorter leukocyte telo-mere length coupled with lower expression of telomerase genes in patients with essential hypertension[J]. Int J Med Sci, 2020, 17(14):2180-2186.
[11] Paik JK, Kang R, Cho Y, et al. Association between genetic variations affecting mean telomere length and the prevalence of hypertension and coronary heart disease in Koreanss[J]. Clin Nutr Res, 2016, 5(4):249-260.
[12] 中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 急性心力衰竭诊断和治疗指南[J]. 中华心血管病杂志, 2010, 38(3):195-208.
[13] Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci[J]. Cell Res, 2005, 15(2):97-98.
[14] Yim J, Cho H, Rabkin SW. Gene expression and gene associations during the development of heart failure with preserved ejection fraction in the Dahl salt sensitive model of hypertension[J]. Clin Exp Hypertens, 2018, 40(2):155-166.
[15] Yin ZQ, Xing WH. Progress in gene therapy for chronic heart failure[J]. Heart Surg Forum, 2018, 21(2):E075-E083.
[16] Albuquerque FN, Brandão AA, Silva DA, et al. Angiotensin-converting enzyme genetic polymorphism: its impact on cardiac remodeling[J]. Arq Bras Cardiol, 2014, 102(1):70-79.
文章导航

/